… to distinguish bacterial EV-associated LPS from other LPS products (… measured bacterial
EV-associated LPS and other LPS … LPS in two dimensions to separate bacterial EV-associated …

… We review the use of human LPS models, focussing on the underlying mechanistic insights
… and pulmonary LPS challenge. We discuss variables that may influence the response to LPS …

… There were significant differences in plasma level for matrix metalloproteinase (MMP)-3,
interleukin (IL)-27, IL-8, IL-4, tumour necrosis factor-alpha, MMP-1, IL-15, IL-21, IL-10, and IL-1 …

… LPS is able to trigger inflammation through both intracellular and extracellular pathways. …
LPS and host cells first involve LPS binding to LPS binding protein (LBP), a carrier. The LPS-…

… of gram-negative bacteria and their LPS have not been … bacteria and LPS in AD. Furthermore,
we discuss the possibility of using gram-negative bacteria and gram-negative bacterial …

… Interleukin (IL)-8 is a chemokine that is essential for inflammation and angiogenesis. IL-8
expression is elevated in tumor cell lines and tissues, as well as in peripheral blood obtained …

… as interleukin 6 (IL-6), interleukin 10 (IL-10), interleukin 8 (IL-8), and macrophage migration
inhibitory factor (MIF) (52, 53). Similar to the finding of Mu et al. (54), our present study found …

… exposure, (5) 12 h of LPS exposure followed by LPS removal for 24 h before restimulating
with LPS for an additional 12 h (RPT), and (6) 12 h of LPS exposure followed by LPS removal …

… of sepsis, considerable evidence demonstrates that LPS-induced signalling and immune …
mechanisms of LPS-induced signalling and emphasises the crucial contribution of LPS to …

… target genes interleukin-8 (IL-8) and interleukin-1β (IL-1β) was also increased in the LPS-…
reaction (ELISA) kits found that the levels of interleukin-6 (IL-6) and tumor necrosis factor-a (…